Abrilumab is a fully human monoclonal antibody directed against alpha4beta7. Abrilumab selectively binds the alpha4beta7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD)[1].
Molecular Weight:
(143.8 kDa)
Purity:
98.35
CAS Number:
[1342290-43-0]
Target:
Integrin
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted